EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence and survival of Lung Cancer: A retrospective population-based cohort (Monastir, Tunisia: 2002–2022)

Wafa Dhouib, Amani Maatouk, Cyrine Bennasrallah, Mariem Kacem, Syrine Doghri, Ahmed Trigui iD, Mounib Bouazizi, Lamis Milad, Manel Ben Fredj, Ines Bouanène, Hela Abroug, Naceur Rouatbi und 4 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0338140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wafa Dhouib und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Preventive Medicine, University Hospital Fattouma Bourguiba of Monastir, University of Monastir, Faculty of Medicine o…. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lung cancer (LC) remains one of the most lethal malignancies worldwide. In Tunisia, LC population-level data is limited. This study aimed to estimate the incidence, mortality, trends burden and survival outcomes of LC over two decades in Monastir (Tunisia).

Methods

We conducted a retrospective population-based cohort including all LC patients diagnosed between 2002 and 2014 in the governorate of Monastir, with follow-up until 2022. Age-standardized incidence and mortality rates (ASIR and ASMR) were calculated and expressed per 100,000 Person-Years (PY). Trends were analyzed using Joinpoint regression to determine Annual Percent Change (APC). Disability-Adjusted Life Years (DALYs), Years of Life Lost (YLL), and Years Lived with Disability (YLD) were computed. Survival analysis was performed using Kaplan–Meier estimates, and multivariable Cox proportional hazards regression was used.

Results

LC ASIR per 100,000 PY was 18.37 (95% CI: 15.1–21.7), 33.63 (29.3–38.0) in males, and 4.50 (2.75–6.41) in females. ASMR per 100,000 PY was 12.33 (9.2–15.84), 24.84 (19.9–29.82) in males, and 2.0 (0.6–3.42) in females. Incidence showed a significant upward trend (APC 8.23%, 95% CI: 2.66–16.12), particularly in females (APC 17.99%, 95% CI: 9.86; 33.27). Projected ASIRs were 43.7 per 100,000 PY in 2025 (95% CI: 37.1–50.3) and 64.7 per 100,000 PY in 2030 (95% CI: 56.7–72.7). DALYs attributable to LC were 1,328 per 100,000 PY, comprising 1,198.8 YLLs and 129.2 YLDs. One-year and five-year survival rates were 43.2% (95% CI: 36.6–49.8) and 22.1% (95% CI: 17.4–26.8), respectively, with a median survival of 10 months (95% CI: 8.9–11.0). Survival was higher among females, younger patients (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHumansFemaleTunisiaMaleRetrospective StudiesMiddle AgedIncidenceAgedAdultDisability-Adjusted Life YearsSurvival RateAged, 80 and overKaplan-Meier Estimate

Autor:innen und Institutionen

  • Department of Epidemiology and Preventive Medicine, University Hospital Fattouma Bourguiba of Monastir, University of Monastir, Faculty of Medicine of Monastir, Monastir, Tunisia.
  • Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, University of Monastir, Faculty of Medicine of Monastir, Monastir, Tunisia.
  • National Institut of Public health, University of ElManar, Faculty of Medicine of Tunis, Tunis, Tunisia.
  • Department of Social Medicine, University Hospital of Sfax, Faculty of Medicine of Sfax, Sfax, Tunisia.
  • Department of Family Medicine, University of Monastir, Faculty of Medicine of Monastir, Monastir, Tunisia.
  • Department of community and Preventive Medicine, Regional Hospital of Ksar Hellal, Faculty of Medicine of Monastir, Monastir, Tunisia.

ORCID-Profile: Ahmed Trigui, Asma Belguith Sriha

Zitieren

APA

Dhouib, W., Maatouk, A., Bennasrallah, C., Kacem, M., Doghri, S., Trigui, A., Bouazizi, M., Milad, L., Ben Fredj, M., Bouanène, I., Abroug, H., Rouatbi, N., Zaied, S., Mokni, M., Belguith Sriha, A., & Zemni, I. (2025). Incidence and survival of Lung Cancer: A retrospective population-based cohort (Monastir, Tunisia: 2002–2022). PLOS One. https://doi.org/10.1371/journal.pone.0338140

Vancouver

Dhouib W, Maatouk A, Bennasrallah C, Kacem M, Doghri S, Trigui A, et al. Incidence and survival of Lung Cancer: A retrospective population-based cohort (Monastir, Tunisia: 2002–2022). PLOS One. 2025. doi:10.1371/journal.pone.0338140

BibTeX
@article{Dhouib2025,
  author = {Dhouib, Wafa and Maatouk, Amani and Bennasrallah, Cyrine and Kacem, Mariem and Doghri, Syrine and Trigui, Ahmed and Bouazizi, Mounib and Milad, Lamis and Ben Fredj, Manel and Bouanène, Ines and Abroug, Hela and Rouatbi, Naceur and Zaied, Sonia and Mokni, Moncef and Belguith Sriha, Asma and Zemni, Imen},
  title = {Incidence and survival of Lung Cancer: A retrospective population-based cohort (Monastir, Tunisia: 2002–2022)},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0338140}
}
Kostenlos starten →